VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of financial results.14-08-2021
14-08-2021
VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of AGM prior publication.13-08-2021
VENUS REMEDIES LTD. - 526953 - Financial Results For The Quarter Ended On 30.06.2021.
Financial Results for the quarter ended on 30.06.2021 as enclosed.12-08-2021
VENUS REMEDIES LTD. - 526953 - Board Meeting Outcome for Outcome Of Board Meeting Dated 12.08.2021
Outcome of Board Meeting dated 12.08.2021 as enclosed.12-08-2021
VENUS REMEDIES LTD. - 526953 - Clarification On Price Movement
This has reference to BSE email dated 11.08.2021 with regard to Clarification on Price Movement of Venus Remedies Limited. In this regard we wish to inform you that Company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 from time to time and has not withheld any material information that in our opinion would have a bearing on the price / volume behavior in the company''s script. The said significant movement in the share price is purely due to market condition and absolutely market driven.11-08-2021
Venus Remedies Ltd - 526953 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 12Th August 2021
VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on Thursday, 12th August 2021 inter alia consider and approve as below: 1. Unaudited Financial Results for the quarter ended on 30th June 2021 2. Finalization of date of 32nd Annual General Meeting of the Company. 3. To consider draft notice of AGM along with draft Directors' Report and Corporate Governance Report for FY 2020-21. 4. Any other business with the permission of Chair. Further, as informed vide letter dated 30.06.2021, the trading window would remain closed till 48 hours from the publication of financial results for designated persons and their immediate relatives, in view of the aforesaid Board meeting.04-08-2021
VENUS REMEDIES LTD. - 526953 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 19, 2021 for Pawan Chaudhary & Mrs Manu Chaudhary19-07-2021
Venus Remedies Ltd - 526953 - RELEASE OF ENTIRE ENCUMBRANCE ON PROMOTERS' SHARES
This has reference to our letter dated 19.07.2021 regarding disclosure under Regulation 31(1) & 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 regarding release of encumbrance on 8,30,000 equity shares of promoters. Now, in furtherance to above said letter, we wish to inform our esteemed shareholders that with the said release, the entire shareholding of the promoters & promoter group is now free from all encumbrances.19-07-2021
VENUS REMEDIES LTD. - 526953 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under Regulation 39(3) of SEBI (LODR) Regulations, 2015.16-07-2021
Venus Remedies enters consumer healthcare business
While the consumer healthcare industry is poised to grow at a rate of 12-15% per annum, the pain management segment is among the largest, accounting for 30% of the industry15-07-2021